Company Comparison
Fulcrum Therapeutics vs 10x Genomics
Side-by-side comparison of two portfolio companies — sector, funding stage, investors, valuation, and more.
| Metric | Fulcrum Therapeutics | 10x Genomics |
|---|---|---|
| Sector | Biotech | Biotech |
| Headquarters | Cambridge, Massachusetts | — |
| Founded | 2016 | — |
| Status | Active | Active |
| Last Funding Stage | IPO | — |
| Total Funding | $200M | — |
| Valuation | — | — |
What They Build
Fulcrum Therapeutics
Clinical-stage biopharmaceutical company developing small molecule drugs for genetically defined diseases using gene modulation approach.
10x Genomics
10x Genomics, Inc. is an American biotechnology company that designs and manufactures sequencing technologies for use in scientific research, with a focus on product development for single-cell and spatial omics.
Key Investors
Sector Overlap
Both Fulcrum Therapeutics and 10x Genomics operate in Biotech.
Browse all Biotech companies →